The online version of this article (https://doi.org/10.1186/s12885-017-3954-5) contains supplementary material, which is available to authorized users.
Regulated cell death (RCD) is a mechanism by which the cell activates its own machinery to self-destruct. RCD is important for the maintenance of tissue homeostasis and its deregulation is involved in diseases such as cervical cancer. IMMUNEPOTENT CRP (I-CRP) is a dialyzable bovine leukocyte extract that contains transfer factors and acts as an immunomodulator, and can be cytotoxic to cancer cell lines and reduce tumor burden in vivo. Although I-CRP has shown to improve or modulate immune response in inflammation, infectious diseases and cancer, its widespread use has been limited by the absence of conclusive data on the molecular mechanism of its action.
In this study we analyzed the mechanism by which I-CRP induces cytotoxicity in HeLa cells. We assessed cell viability, cell death, cell cycle, nuclear morphology and DNA integrity, caspase dependence and activity, mitochondrial membrane potential, and reactive oxygen species production.
I-CRP diminishes cell viability in HeLa cells through a RCD pathway and induces cell cycle arrest in the G2/M phase. We show that the I-CRP induces caspase activation but cell death induction is independent of caspases, as observed by the use of a pan-caspase inhibitor, which blocked caspase activity but not cell death. Moreover, we show that I-CRP induces DNA alterations, loss of mitochondrial membrane potential, and production of reactive-oxygen species. Finally, pretreatment with N-acetyl-L-cysteine (NAC), a ROS scavenger, prevented both ROS generation and cell death induced by I-CRP.
Our data indicate that I-CRP treatment induced cell cycle arrest in G2/M phase, mitochondrial damage, and ROS-mediated caspase-independent cell death in HeLa cells. This work opens the way to the elucidation of a more detailed cell death pathway that could potentially work in conjunction with caspase-dependent cell death induced by classical chemotherapies.
Additional file 1: Figure S1. (A) ROS levels were measured by flow cytometry through DCFDA staining in SiHa cells left alone or pretreated with NAC or QVD.oph and then treated with I-CRP (1.25 U/mL) for 24 h. (B) The effect on cell death of cells left alone or pretreated with NAC or QVD.oph and then treated with I-CRP (1.25 U/mL) for 24 h, was analyzed by flow cytometry through Annexin-V staining. The results were analyzed and graphed. (PDF 20 kb)12885_2017_3954_MOESM1_ESM.pdf
Additional file 2: Figure S2. Left, caspase-3 activity of HeLa cells left untreated or pretreated with Nac, and then treated with I-CRP. Right, the results obtained were analyzed and graphed as the percentage of HeLa cells positive for caspase-3 activity. (PDF 37 kb)12885_2017_3954_MOESM2_ESM.pdf
Bell MC, Alvarez RD. Chemoprevention and vaccines: a review of the nonsurgical options for the treatment of cervical dysplasia. Int J Gynecol Cancer Blackwell Science Inc. 2005;15:4–12. CrossRef
Hazra B, Ghosh S, Kumar A, Pandey BN. The prospective role of plant products in radiotherapy of cancer: a current overview. Front Pharmacol. 2011;2:94. PubMed
PEREZ-TAPIA SM, LOPEZ-ISLAS I, FUENTE-GRANADA MDLA, ARRATIA-VALDELAMAR K, JIMENEZ-GALLEGOS N, RODRIGUEZ-FLORES A, et al. Use of dialyzable leukocyte extracts (DLE) in patients with severe sepsis (49.35). J Immunol. 2007;178:S90.
Mendoza-Gamboa E, Franco-Molina MA, Zapata-Benavides P, Castillo-Tello P, Vera-García ME, Tamez-Guerra RS, et al. Bovine dialyzable leukocyte extract modulates AP-1 DNA-binding activity and nuclear transcription factor expression in MCF-7 breast cancer cells. Cytotherapy. 2008;10:212–9. CrossRefPubMed
Lara HH, Ixtepan-Turrent L, Garza-Treviño EN, Tamez-Guerra R, Rodriguez-Padilla C. Clinical and immunological assessment in breast cancer patients receiving anticancer therapy and bovine dialyzable leukocyte extract as an adjuvant. Exp Ther Med Spandidos Publications. 2010;1:425–31. CrossRef
Coronado-Cerda EE, Franco-Molina MA, Mendoza-Gamboa E, Prado-García H, Rivera-Morales LG, Zapata-Benavides P, et al. In Vivo Chemoprotective activity of bovine dialyzable leukocyte extract in mouse bone marrow cells against damage induced by 5-fluorouracil. J Immunol Res Hindawi Publishing Corporation. 2016;2016:1–10.
Arnaudov A, Kostova Z. Dialysable leukocyte extracts in immunotherapy. Med. Biotechnol: Taylor & Francis; 2015.
Leist M, Jäättelä M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol Nature Publishing Group. 2001;2:589–98. CrossRef
IARC. World Cancer Report 2014. 2014.
Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst Oxford University Press. 2013;105:256–65. CrossRef
Fudenberg HH. DIALYZABLE TRANSFER FACTOR IN THE TREATMENT OF HUMAN OSTEOSARCOMA: AN ANALYTIC REVIEW. Ann. N. Y. Acad. Sci. Blackwell Publishing Ltd. 1976;277:545–57.
Pizza G, De Vinci C, Cuzzocrea D, Menniti D, Aiello E, Maver P, et al. A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer. Biotherapy Kluwer Academic Publishers. 1996;9:123–32.
Pilotti V, Mastrorilli M, Pizza G, De Vinci C, Busutti L, Palareti A, et al. Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Biotherapy Kluwer Academic Publishers. 1996;9:117–21.
Franco-Molina MA, Mendoza-Gamboa E, Zapata-Benavides P, Vera-Garcia M. E. Castillo-Tello P, de la Fuente AG, Rodríguez-Padilla C. IMMUNEPOTENT CRP (bovine dialyzable leukocyte extract) adjuvant immunotherapy: a phase I study in non-small cell lung cancer patients. Cytotherapy. 2008;10:490–6. CrossRefPubMed
Krishnaveni M. A review on transfer factor an immune modulator. Drug Invent Today. 2013;5:153–6. CrossRef
Hamprecht KH, Vötsch W, Anderer FA. A Dialysable acid factor from human leukocyte extracts activates tumor cell Lysis mediated by human Monocytes and natural killer cells. Oncol Res Treat Karger Publishers. 2009;12:120–7. CrossRef
Spitler LE, Levin AS, Wybran J. Combined immunotherapy in malignant melanoma. Cell Immunol Academic Press. 1976;21:1–19. CrossRef
Láng I, Nékám K, Gergely P, Petrányi G. Effect of in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity. Clin Immunol Immunopathol Academic Press. 1982;25:139–44. CrossRef
Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N. Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta - Mol Cell Res. 1833;2013:3448–59.
Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ Macmillan Publishers Limited. 2014;22:58–73. CrossRef
Dubois A, Ginet C, Furstoss N, Belaid A, Hamouda MA, El Manaa W, et al. Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death. Oncotarget. 2016;7(18):26120–36. CrossRefPubMedPubMedCentral
McLaughlin B. The kinder side of killer proteases: Caspase activation contributes to neuroprotection and CNS remodeling. Apoptosis Kluwer Academic Publishers. 2004;9:111–21.
Gajek A, Denel M, Bukowska B, Rogalska A, Marczak A. Pro-apoptotic activity of new analog of anthracyclines – WP 631 in advanced ovarian cancer cell line. Toxicol Vitr. 2014;28:273–81. CrossRef
Dric Artus C, Boujrad H, Bouharrour A, Lle Brunelle M-N, Hoos S, Yuste VJ, et al. AIF promotes chromatinolysis and caspase- independent programmed necrosis by interacting with histone H2AX. EMBO J. 2010;2943:1585–99. CrossRef
Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, et al. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res American Association for Cancer Research. 1994;54:448–54.
Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res. 2001;7:1466–73. PubMed
Hartwell LH, Kastan MB. Cell cycle control and cancer. Science (80- ). 1994;266:1821. CrossRef
Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature Nature Publishing Group. 2004;432:316–23.
Zhang Z, Wang C-Z, Du G-J, Qi L-W, Calway T, He T-C, et al. Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells. Int J Oncol Spandidos Publications. 2013;43:289–96. CrossRef
Wu C-C, Huang K-F, Yang T-Y, Li Y-L, Wen C-L, Hsu S-L, et al. The Topoisomerase 1 inhibitor Austrobailignan-1 isolated from Koelreuteria Henryi induces a G2/M-phase arrest and cell death independently of p53 in non-small cell lung cancer cells. PLoS One. 2015;10:e0132052. Fei P, editor. Public Library of Science CrossRefPubMedPubMedCentral
Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O, Valko M, et al. Oxidative stress and antioxidant defense. World Allergy Organ J BioMed Central. 2012;5:9–19. CrossRef
Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol Nature Research. 2013;10:9–17. CrossRef
Jacobson MD. Reactive oxygen species and programmed cell death. Trends Biochem Sci Elsevier Current Trends. 1996;21:83–6. CrossRef
Rodríguez-Serrano M, Bárány I, Prem D, Coronado M-J, Risueño MC, Testillano PS. NO, ROS, and cell death associated with caspase-like activity increase in stress-induced microspore embryogenesis of barley. J Exp Bot Oxford University Press. 2012;63:2007–24. CrossRef
Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist’s guide to reactive oxygen species. Nat Rev Immunol Nature Publishing Group. 2013;13:349–61. CrossRef
Tait SWG, Green DR. Cut. 2009;27:6452–61.
Kang Y-H, Yi M-J, Kim M-J, Park M-T, Bae S, Kang C-M, et al. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res. 2004;64:8960–7. CrossRefPubMed
Franco-Molina MA, Mendoza-Gamboa E, Castillo-León L, Tamez-Guerra RS, Rodríguez-Padilla C. Bovine dialyzable leukocyte extract modulates the nitric oxide and pro-inflammatory cytokine production in Lipopolysaccharide-stimulated Murine peritoneal macrophages in vitro. 2 Madison Avenue Larchmont, NY 10538 USA: Mary Ann Liebert, Inc; 2005.
- IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production
Ana Carolina Martínez-Torres
Moises Armides Franco-Molina
- BioMed Central
Neu im Fachgebiet Onkologie
Mail Icon II